For the Inventor, By the Inventor

Enter assignee name

Lorus Therapeutics Inc.

USPTO Granted Patents = 10

% Expired Patents = 70.0

CIPO Patents = 3

EPO Patents = 5

Trademarks = 1

Forward Citations = 50

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Aiping H Young (7 out of 19 patents)

Yoon S Lee (5 out of 11 patents)

Mario Huesca (4 out of 7 patents)

4. Jim A Wright (4 out of 12 patents)

5. Romeo G Rang (3 out of 3 patents)

6. Raed Al-Qawasmeh (2 out of 4 patents)

7. Lisa Lock (1 out of 2 patents)

8. Howard Cukier (1 out of 1 patent)

9. Venkata Nedunuri (1 out of 1 patent)

10. Robert Peralta (1 out of 1 patent)

11. Raed H Al-Qawasmeh (1 out of 2 patents)

12. Ming Yu Cao (1 out of 1 patent)

13. Aye Aye Khine (1 out of 1 patent)

14. Paul B Percheson (1 out of 1 patent)

15. Yoon Lee (0 patent)

10 patents: Sort by Forward Citations

1. 9309247 - 2-substituted imidazo[4,5-D]phenanthroline derivatives and their use in the treatment of cancer (2016-04-12),

2. 8394815 - 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents (2013-03-12),

3. 8287851 - Use of interleukin 17E for the treatment of cancer (2012-10-16),

4. 8148392 - 2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatment of cancer (2012-04-03),

5. 7968526 - Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer (2011-06-28),

6. 7884120 - 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents (2011-02-08),

7. 7405205 - Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase (2008-07-29),

8. 6596319 - Immunomodulating compositions for treatment of immune system disorders (2003-07-22),

9. 6551623 - Immunomodulating compositions from bile (2003-04-22),

10. 6280774 - Immunomodulating compositions from bile (2001-08-28),

Lorus Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative cancer therapeutics. With a strong pipeline of novel drugs targeting a variety of cancer types, Lorus is dedicated to advancing cancer treatment and improving patient outcomes.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

10 Patents

#135 in

#1,521 in Canada

#55,954 in the World

Lorus Therapeutics Inc.

Forward Citations = 50

14 inventors:

Aiping H Young (7 out of 19 patents)

Yoon S Lee (5 out of 11 patents)

Mario Huesca (4 out of 7 patents)

4. Jim A Wright (4 out of 12 patents)

5. Romeo G Rang (3 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…